Although it appears to be straight from the comic book, Vivacoal is a genuine functional titanium heart. Metal devices are ultimately intended as an alternative to human donor organs, but were first used last year as a stop for hospital patients awaiting transplants. According to the creator And the groundbreaking invention, representative of a St. Vincent hospital in Sydney, Australia, recently marked a major milestone. The man survived over 100 days with Vivacoll implants, pumping blood inside him and temporarily discharged from the medical facility.
The fundamental principles of titanium equipment were first envisaged in 2001 by a biomedical engineer named Daniel Tims. Tims, the son of a plumber, started it. By using hardware store pipes and valves to mimic the human circulation system, but has developed something that will become Vivacoll over the next 25 years. The end reaction works without an actual valve and relies on a single moving part. This magnetically does not come into contact with the titanium frame itself and spins rotor spin between the two chambers, eliminating the risk of gentle corrosion and malfunction. The overall device weighs less than 1.5 pounds and features an external battery located on the abdomen. They are also not only small enough to fit both male and female, but also 12 year old children. Research also suggests that Bivocar can support adults during intense exercise.
In 2024, US and Australian doctors made history Install successfully A pump that is almost fist-sized for a total of five patients. One of them, a man in his 40s dealing with severe heart failure, could only walk a few feet before losing his breath. However, in the weeks following the six-hour procedure, the patient regained sufficient strength and mobility to leave the hospital until the donor’s heart was available. He returned in early March to receive a human transplant, but is now recovering. Announcement on March 12th From St. Vincent Hospital.
“Heart failure kills around 5,000 Australians each year. We have worked towards this moment for years and are extremely proud to be the first Australian team to carry out this procedure.” said in another statement.
The Bivacor is not on sale yet, but four more devices are in place for use in Australia by the end of 2025. In the future, these titanium hearts will not only serve as temporary tools, but will also be long-term and perhaps lasting alternatives.